GENELUX CORPORATION (GNLX) Net Margin
- 2024-03-31: Net Margin -98125.00%.
- 2023-03-31: Net Margin -6096.47%.
- 2022-12-31: Net Margin -5139.71%.
- 2022-09-30: Net Margin 44.63%.
Complete source-backed net margin history.
- Available history
- 2022-09-30 to 2025-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2024-03-31 | -98125.00% |
| 2023-03-31 | -6096.47% |
| 2022-12-31 | -5139.71% |
| 2022-09-30 | 44.63% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -401812.50% |
| 2024-12-31 | -373362.50% |
| 2023-12-31 | -16645.29% |
| 2022-12-31 | -47.05% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |